Clinical trial
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
NCT00405496 · Sirion Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00405496 |
|---|---|
| Title | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis |
| Official title | Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Anterior Uveitis (Inluding Iritis, Cyclitis, Iridocyclitis, and Panuveitis). |
| Lead sponsor | Sirion Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anterior Uveitis |
| Intervention type | Drug |
| Interventions | Difluprednate Ophthalmic Emulsion |
| Enrollment | 24 |
| Start date | Mar 1, 2000 |
| Completion | Apr 1, 2001 |
| First posted | Nov 30, 2006 |
| Last update posted | Nov 30, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: